MSN Laboratories Private Limited — Telmisartan Exporter Profile
Indian Pharmaceutical Exporter · #8 for Telmisartan · $7.1M export value · DGFT Verified
MSN Laboratories Private Limited is the #8 Indian exporter of Telmisartan with $7.1M in export value and 619 verified shipments. MSN Laboratories Private Limited holds a 0.1% market share in Telmisartan exports across 23 countries. The company exports 32 pharmaceutical products worth $252.1M across 15 therapeutic categories.
MSN Laboratories Private Limited — Telmisartan Export Profile: Buyers & Destinations
Where Does MSN Laboratories Private Limited Export Telmisartan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $3.1M | 160 | 46.2% |
| MAURITIUS | $410.6K | 28 | 6.1% |
| NIGERIA | $392.3K | 43 | 5.8% |
| ZAMBIA | $380.3K | 36 | 5.6% |
| UGANDA | $307.6K | 55 | 4.5% |
| MYANMAR | $303.9K | 37 | 4.5% |
| TANZANIA | $288.0K | 56 | 4.3% |
| NAMBIA | $240.8K | 12 | 3.6% |
| PERU | $223.5K | 25 | 3.3% |
| ECUADOR | $196.2K | 15 | 2.9% |
MSN Laboratories Private Limited exports Telmisartan to 28 countries. The largest destination is COLOMBIA accounting for 46.2% of MSN Laboratories Private Limited's Telmisartan shipments, followed by MAURITIUS (6.1%) and NIGERIA (5.8%). These destinations reflect MSN Laboratories Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Telmisartan from MSN Laboratories Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MSN LABS AMERICAS SAS | COLOMBIA | $1.6M | 64 |
| TO THE ORDER OF | NIGERIA | $996.8K | 114 |
| TO THE ORDER | COLOMBIA | $491.3K | 50 |
| LWIN AND MYINT TRADING COMPANY | MYANMAR | $248.5K | 32 |
| MSN LABS AMERAICAS SAS | COLOMBIA | $225.9K | 8 |
| SCOTT HEALTH LTD | MAURITIUS | $205.0K | 12 |
| TO THE ORDER OF., | JAMAICA | $154.4K | 15 |
| MSN LABS AMERAICAS SAS NIT | COLOMBIA | $136.7K | 3 |
| REDDY PHARMA LTD | TANZANIA | $136.2K | 17 |
| COSPHARM T/A M PLUS DISTRIBUTORS | NAMBIA | $123.6K | 6 |
MSN Laboratories Private Limited supplies Telmisartan to 79 buyers globally. The largest buyer is MSN LABS AMERICAS SAS (COLOMBIA), followed by TO THE ORDER OF (NIGERIA) and TO THE ORDER (COLOMBIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Telmisartan Export Value and How Much Does MSN Laboratories Private Limited Contribute?
India exported $172.2M worth of Telmisartan through 11,086 shipments from 413 suppliers to 132 countries, serving 1,116 buyers globally. MSN Laboratories Private Limited contributes $7.1M to this total, accounting for 0.1% of India's Telmisartan exports. MSN Laboratories Private Limited ships Telmisartan to 28 countries through 79 buyers.
What Is the Average Shipment Value for MSN Laboratories Private Limited's Telmisartan Exports?
MSN Laboratories Private Limited's average Telmisartan shipment value is $11.5K per consignment, based on 619 shipments totaling $7.1M. The largest destination is COLOMBIA (46.2% of MSN Laboratories Private Limited's Telmisartan exports).
How Does MSN Laboratories Private Limited Compare to Other Indian Telmisartan Exporters?
MSN Laboratories Private Limited ranks #8 among 413 Indian Telmisartan exporters with a 0.1% market share. The top 3 exporters are CIPLA LIMITED ($81.0M), INTAS PHARMACEUTICALS LIMITED ($15.5M), MYLAN LABORATORIES LIMITED ($12.0M). MSN Laboratories Private Limited processed 619 shipments to 23 destination countries.
What Telmisartan Formulations Does MSN Laboratories Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RENANGIO 80 (TELMISARTAN 80MG) 3X10 | $506.9K | 36 |
| RENANGIO PLUS 80+12.5 (TELMISARTAN + HYDROCHLOROTHIAZIDE 80+12.5) 3X10 | $165.5K | 11 |
| RENANGIO PLUS 80+12.5 (TELMISARTAN+HYDROCHLOROT HIAZIDE 80+12.5) 3X10 | $152.7K | 10 |
| RENANGIO 40 TELMISARTAN 40MG 3X10 | $112.7K | 4 |
| Renangio Plus 80+12.5 (Telmisartan+Hydrochlorot hiazide 80+12.5) 3x10 | $92.6K | 2 |
| RENANGIO 40 (TELMISARTAN 40MG) 3X10 | $90.8K | 9 |
| CILZEC 40 (TELMISARTAN 40MG) 3X10NOS | $76.9K | 8 |
| Renangio Plus 80+25 (Telmisartan+Hydrochlorot hiazide 80+25) 3x10 | $62.2K | 2 |
| RENANGIO PLUS 80 + 25 (TELMISARTAN + HYDROCHLOROTHIAZIDE 80 + 25) 3X10 | $54.8K | 5 |
| SAFETELMI 80 (TELMISARTAN 80MG) 3X10 | $53.9K | 8 |
MSN Laboratories Private Limited exports 400 distinct Telmisartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RENANGIO 80 (TELMISARTAN 80MG) 3X10 with 36 shipments worth $506.9K.
Regulatory Requirements: Exporting Telmisartan to Key Markets
What MSN Laboratories Private Limited must comply with to export Telmisartan to its top destination countries
Nigeria — NAFDAC
Approval Process
Drug registration under NAFDAC guidelines. WHO-type CPP from India required.
Timeline: 6–18 months
GMP & Export Requirements
WHO GMP compliance; NAFDAC conducts overseas plant inspections
Certificate of Pharmaceutical Product (CPP) from CDSCO India; NAFDAC import permit
Note: India is the largest pharma supplier to Nigeria. NAFDAC has intensified Indian site inspections.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does MSN Laboratories Private Limited Compare to Nearest Telmisartan Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | GLENMARK PHARMACEUTICALS LIMITED | $9.3M | 532 | 17 | $17.5K |
| 7 | MICRO LABS LIMITED | $8.9M | 659 | 23 | $13.6K |
| 8 | MSN LABORATORIES PRIVATE LIMITED ★ | $7.1M | 619 | 23 | $11.5K |
| 9 | INVENTIA HEALTHCARE LIMITED | $5.3M | 197 | 8 | $26.8K |
| 11 | TORRENT PHARMACEUTICALS LTD | $3.7M | 98 | 7 | $37.7K |
MSN Laboratories Private Limited ranks #8 among 413 Indian Telmisartan exporters. Average shipment value of $11.5K compared to the market average of $416.8K. The closest competitors by value are GLENMARK PHARMACEUTICALS LIMITED and MICRO LABS LIMITED.
Which Indian Ports Ship Telmisartan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 1,766 | 15.9% |
| SAHAR AIR | 1,729 | 15.6% |
| DELHI AIR CARGO ACC (INDEL4) | 1,003 | 9.0% |
| NHAVA SHEVA SEA (INNSA1) | 755 | 6.8% |
| DELHI AIR | 623 | 5.6% |
| AHEMDABAD AIR | 402 | 3.6% |
| Bombay Air | 396 | 3.6% |
| JNPT | 377 | 3.4% |
What Other Cardiovascular Products Does MSN Laboratories Private Limited Export?
MSN Laboratories Private Limited also exports these cardiovascular products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on MSN Laboratories Private Limited's Telmisartan Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like MSN Laboratories. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major shipping lines to alter routes. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, impacting the timely delivery of pharmaceutical products. (livemint.com)
Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, potentially benefiting Indian exporters. However, the imposition of tariffs on Indian pharmaceutical products poses a risk to export volumes, as higher tariffs can lead to increased costs and reduced competitiveness in the US market. (orfonline.org)
In the European Union, compliance with the Falsified Medicines Directive (FMD) requires stringent serialization and traceability measures. For companies like MSN Laboratories, adhering to these regulations is crucial to maintain market access and ensure the integrity of their supply chain.
MSN Laboratories Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) guidelines set rigorous quality benchmarks. Any lapses can lead to import bans, product recalls, and reputational damage.
MSN Laboratories' recent legal challenges, such as the patent litigation with Exelixis, Inc., highlight the importance of robust regulatory and intellectual property strategies. Ensuring compliance with evolving quality requirements and proactively addressing regulatory challenges are essential for sustaining export growth and market credibility.
About MSN Laboratories Private Limited
MSN Laboratories Private Limited exports 32 products worth $252.1M. Beyond Telmisartan, top products include Atorvastatin, Rosuvastatin, Ras, Oseltamivir, Calcium. View the complete MSN Laboratories Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Telmisartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Telmisartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: MSN Laboratories Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 619 individual customs records matching MSN Laboratories Private Limited exporting Telmisartan, covering 400 formulations to 28 countries via 79 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 132+ countries, 1,116+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Telmisartan Export Data from MSN Laboratories Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for MSN Laboratories Private Limited's Telmisartan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
MSN Laboratories Private Limited
Full Company Profile →
32 products · $252.1M total trade · 15 categories
Telmisartan Stats
Company Overview
Top Products by MSN Laboratories Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for MSN Laboratories Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Telmisartan. For current shipment-level data, contact TransData Nexus.